References
- Ali, S. S., & Jones, H. (2018). 23. An adverse neuropsychiatric reaction following treatment with hydroxychloroquine: A case report. Rheumatology Advances in Practice, 2(suppl_1). https://doi.org/10.1093/rap/rky033.014
- Bouchentouf, S., & Missoum, N. (2020). Identification of compounds from Nigella Sativa as new potential inhibitors of 2019 novel Coronasvirus (COVID-19): Molecular docking study. https://doi.org/10.26434/chemrxiv.12055716
- Dai, Y., Chen, S., Chai, L., Zhao, J., Wang, Y., & Wang, Y. (2019). Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Critical Reviews in Food Science and Nutrition, 59(sup1), S17–S29. https://doi.org/10.1080/10408398.2018.1501657
- Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
- Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., Dupont, H. T., Honoré, S., Colson, P., Chabrière, E., La Scola, B., Rolain, J., Brouqui, P., & Raoult, D. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, 105949. https://doi.org/10.1016/j.ijantimicag.2020.105949
- Gfeller, D., Grosdidier, A., Wirth, M., Daina, A., Michielin, O., & Zoete, V. (2014). SwissTargetPrediction: A web server for target prediction of bioactive small molecules. Nucleic Acids Research, 42(W1), W32–W38. https://doi.org/10.1093/nar/gku293
- Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D., Du, B., Li, L. J., Zeng, G., Yuen, K. Y., Chen, R. C., Tang, C. L., Wang, T., Chen, P. Y., Xiang, J., Li, S. Y, … China Medical Treatment Expert Group for Covid-19 (2020). Clinical characteristics of Coronavirus disease 2019 in China. The New England Journal of Medicine, NEJMoa2002032. Advance online publication. https://doi.org/10.1056/NEJMoa2002032
- Guastalegname, M., & Vallone, A. (2020). Could chloroquine/Hydroxychloroquine be harmful in coronavirus disease 2019 (COVID-19) treatment? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Sosciety of America, ciaa321. Advance online publication. https://doi.org/10.1093/cid/ciaa321
- Guo, Y., Cao, Q., Hong, Z., Tan, Y., Chen, S., Jin, H., Tan, K., Wang, D., & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research, 7(1),11. https://doi.org/10.1186/s40779-020-00240-0
- Gupta, S., Mishra, K. P., & Ganju, L. (2017). Broad-spectrum antiviral properties of andrographolide. Archives of Virology, 162(3), 611–623. https://doi.org/10.1007/s00705-016-3166-3
- Heald-Sargent, T., & Gallagher, T. (2012). Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses, 4(4), 557–580. https://doi.org/10.3390/v4040557
- Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/s0140-6736(20)30183-5 https://doi.org/10.1016/S0140-6736(20)30183-5
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of mpro from COVID-19 virus and discovery of its inhibitors. Nature. https://doi.org/10.1038/s41586-020-2223-y
- Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007). Relating protein pharmacology by ligand chemistry. Nature Biotechnology, 25(2), 197–206. https://doi.org/10.1038/nbt1284
- Khaerunnisa, S., Kurniawan, H., Awaluddin, R., Suhartati, S., Soetjipto, S. (2020). Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints, 2020030226. https://doi.org/10.20944/preprints202003.0226.v1
- Khan, R. J., Jha, R. K., Amera, G., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-Cov-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like Proteinase and 2’-O-RiboseMethyltransferase. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/10.1080/07391102.2020.1753577
- Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-Cov-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/10.1080/07391102.2020.1751298
- Krishnasamy, K., Ramalingam, S., Karupannan, S., Padmanaban, P., Vijayan, S., Sheriff, K., & Palani, G. (2018). Anti-dengue activity of Andrographis paniculata extracts and quantification of dengue viral inhibition by SYBR green reverse transcription polymerase chain reaction. AYU (an International Quarterly Journal of Research in Ayurveda)), 39(2), 87. https://doi.org/10.4103/ayu.AYU_144_17
- Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-Cov-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–6. https://doi.org/10.1080/07391102.2020.1752802
- Pelle, M. T., & Callen, J. P. (2002). Adverse cutaneous reactions to Hydroxychloroquine are more common in patients with Dermatomyositis than in patients with cutaneous lupus Erythematosus. Archives of Dermatology, 138(9), 1231–1233. https://doi.org/10.1001/archderm.138.9.1231
- Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). PkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
- Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Janke, C., Guggemos, W., Seilmaier, M., Drosten, C., Vollmar, P., Zwirglmaier, K., Zange, S., Wölfel, R., & Hoelscher, M. (2020). Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal of Medicine, 382(10), 970–971. https://doi.org/10.1056/NEJMc2001468
- Sarma, P., Sekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D. P., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1753580
- Seubsasana, S., Pientong, C., Ekalaksananan, T., Thongchai, S., & Aromdee, C. (2011). A potential Andrographolide analogue against the replication of herpes simplex virus type 1 in Vero cells. Medicinal Chemistry, 7(3), 237–244. https://doi.org/10.2174/157340611795564268
- Tailor, R., Elaraoud, I., Good, P., Hope-Ross, M., & Scott, R. A. (2012). A case of severe hydroxychloroquine-induced retinal toxicity in a patient with recent onset of renal impairment: A review of the literature on the use of Hydroxychloroquine in renal impairment. Case Reports in Ophthalmological Medicine, 2012, 1–3. https://doi.org/10.1155/2012/182747
- Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005). Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology Journal, 2(1), 69.https://doi.org/
- Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/10.1038/s41422-020-0282-0
- Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, 323(11), 1061. https://doi.org/10.1001/jama.2020.1585
- Wintachai, P., Kaur, P., Lee, R. C., Ramphan, S., Kuadkitkan, A., Wikan, N., Ubol, S., Roytrakul, S., Chu, J. J., & Smith, D. R. (2015). Activity of andrographolide against chikungunya virus infection. Scientific Reports, 5(1), 14179. https://doi.org/10.1038/srep14179
- Wondafrash, D. Z., Desalegn, T. Z., Yimer, E. M., Tsige, A. G., Adamu, B. A., & Zewdie, K. A. (2020). Potential effect of Hydroxychloroquine in diabetes mellitus: A systematic review on preclinical and clinical trial studies. Journal of Diabetes Research, 2020, 1–10. https://doi.org/10.1155/2020/5214751
- Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-Cov-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y), 368(6489), 409–412. https://doi.org/10.1126/science.abb3405
- Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., … Shi, Z.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7